Updated:
Stassets Investment
Stassets Investment focuses on the healthcare sector, specializing in early-stage investments in pharmaceuticals, diagnostics/medical devices, digital...
Overview
Stassets Investment focuses on the healthcare sector, specializing in early-stage investments in pharmaceuticals, diagnostics/medical devices, digital healthcare, cosmeceuticals, and nutraceuticals. The firm has made 19 investments, including a PIPE investment in Orum Therapeutics on December 18, 2025. Stassets Investment has 2 portfolio exits, with Orum Therapeutics being one of them, exiting on February 14, 2025.
General information
Firm type
Private Equity
Year founded
2017
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Frequently asked questions
What is Stassets Investment's known track record or notable exits?
No portfolio companies, realized exits, or fund-performance metrics are available in public records. The firm does not disclose its investment history, fund vintages, or returns data, making it difficult for external allocators to assess realized track record without direct relationships with the firm.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: